Obermatt
See Similar Stocks →

Aurora Cannabis

TOR:ACB · CA05156X8504
PharmaceuticalsSmall

360

34
EV / EBIT17
Price / Owner Earnings55
Owner Earnings Yield1
Dividend Yield1
Price/Sales79
EV / Gross Profit71
Price/Book71
Return on Capital39
Cash Return on Capital31
Return on Equity45
EBIT Margin15
Gross Profitability41
Accruals48
Owner Earnings Margin16
Sales growth45
Profit Growth95
Long-Term EPS Growth100
Reinvestment46
Price momentum6
Debt load50
Refinancing100
Debt Payback1
Liquidity45
Analyst ratings16
Opinion Changes50
Price Target Upside19
Market mood40
Value Creation2/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Aurora Cannabis doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryCanada
IndustryPharmaceuticals
SizeSmall
TypePublic Company
ExchangeTSX
Employees637
Websiteauroramj.com
ISINCA05156X8504
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
HorticultureCannabisAlternative MedicineManufacturingMedicalPharmaceutical

Description

Aurora Cannabis Inc. (Aurora), through its wholly-owned subsidiaries, focuses on the production, distribution, and sale of cannabis products in Canada and internationally. As of March 31, 2026, the company operated its businesses through the followi…

Analysis

Middle-of-the-road

Aurora Cannabis Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is sturdy. The company scores 2/20 on our value-creation score: not creating value. Analyst sentiment is cautious.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
59
2023202420252026

All-time high

93

Jan 2024

All-time low

46

Mar 2026

Average rank

61

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
79
72
73
24
Price/Earnings
19
10
4
4
Price/Book
71
65
71
80
Dividend Yield
1
1
1
1
Value (overall)
78
43
67
47

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Aurora Cannabis with its peers
High Tide
CVE:HITI
62
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Trulieve Cannabis
CNX:TRUL
39
CountryUSA
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
SNDL
NAQ:SNDL
45
CountryCanada
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
Cronos Group
TOR:CRON
45
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Canopy Growth
TOR:WEED
19
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Cresco Labs
CNX:CL
43
CountryUSA
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →